Please Wait
Applying Filters...
menu
    • menu
    Excipient Market Overview: Clariant sets up its first PEG excipients facility in US; India harmonizes 22 excipient monographs

    DATA COMPILATION
    #PharmaFlow

    Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

    Stock Recap
    #PipelineProspector

    Menu

    Dimetazina

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 58Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    31/03/2026 Valens Molecules
    India
    		 VALENS MOLECULES PRIVATE LIMITED Hyderabad IN R0-CEP 2019-210 - Rev 00 Sulfadimethoxine 2021-10-27 Valid Chemical 2741
    31/03/2026 Zhejiang Jiuzhou Pharmaceutical
    China
    		 ZHEJIANG JIUZHOU PHARMACEUTICAL CO. LTD. Taizhou CN CEP 2025-053 - Rev 00 Sulfadimethoxine 2026-03-24 Valid Chemical 2741
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.